FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroki Maruyama

Research Profile

Procedures

Living Beings

Chemicals & Drugs

Devices

Gene Transfer Techniques

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Hiroki Maruyama; Ichiei Narita; Takuma Takata; Ryushi Tazawa; Jun Tohyama; Yutaka Tsubata; Hidekatsu Yoshioka; Kiyoe Goto; Satoshi Ishii
Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
S Yamamoto; Junichiro James Kazama; Hiroki Maruyama; Shinichi Nishi; Ichiei Narita; Fumitake Gejyo
Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.
Masanori Tsuchida; Terumoto Koike; Masaru Takekubo; Hiroyuki Hirahara; Haruo Hanawa; Hiroki Maruyama; Jun-Ichi Miyazaki; Jun-ichi Hayashi
Electroporation-mediated transfer of plasmid DNA encoding IL-10 attenuates orthotopic tracheal allograft stenosis in rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroki Maruyama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hiroki Maruyama; Ichiei Narita; Takuma Takata; Ryushi Tazawa; Jun Tohyama; Yutaka Tsubata; Hidekatsu Yoshioka; Kiyoe Goto; Satoshi Ishii
Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
Clinical journal of the American Society of Nephrology : CJASN 2013;8(4):629-36.
2008: S Yamamoto; Junichiro James Kazama; Hiroki Maruyama; Shinichi Nishi; Ichiei Narita; Fumitake Gejyo
Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.
Clinical nephrology 2008;70(6):496-502.
2008: Masanori Tsuchida; Terumoto Koike; Masaru Takekubo; Hiroyuki Hirahara; Haruo Hanawa; Hiroki Maruyama; Jun-Ichi Miyazaki; Jun-ichi Hayashi
Electroporation-mediated transfer of plasmid DNA encoding IL-10 attenuates orthotopic tracheal allograft stenosis in rats.
Transplant immunology 2008;19(3-4):173-7.
2008: He Chang; Haruo Hanawa; Tsuyoshi Yoshida; Manabu Hayashi; Hui Liu; Limin Ding; Keita Otaki; Kazuhisa Hao; Kaori Yoshida; Kiminori Kato; Ken Toba; Makoto Kodama; Hiroki Maruyama; Junichi Miyazaki; Yoshifusa Aizawa
Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer.
Circulation journal : official journal of the Japanese Circulation Society 2008;72(5):813-9.
2008: Gen Nakamura; Hiroki Maruyama; Satoshi Ishii; Masaaki Shimotori; Shigemi Kameda; Toru Kono; Jun-Ichi Miyazaki; Ashok Kulkarni; Fumitake Gejyo
Naked plasmid DNA-based alpha-galactosidase A gene transfer partially reduces systemic accumulation of globotriaosylceramide in Fabry mice.
Molecular biotechnology 2008;38(2):109-19.
2008: Kiyoko Hosaka; Junichiro James Kazama; Suguru Yamamoto; Yumi Ito; Noriaki Iino; Hiroki Maruyama; Akihiko Saito; Ichiei Narita; Fumitake Gejyo
Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism.
Journal of bone and mineral metabolism 2008;26(2):185-90.
2007: Kyuma Ota; Hiroki Maruyama; Noriaki Iino; Gen Nakamura; Masaaki Shimotori; Yoshinari Tanabe; Hiroki Tsukada; Fumitake Gejyo
Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2007;13(4):273-5.
2006: Junichiro James Kazama; Kentaro Omori; Suguru Yamamoto; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Yoshiko Iwasaki; Masafumi Fukagawa
Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(3):262-6.
2006: Takeshi Kuroda; Hiroki Maruyama; Masaaki Shimotori; Noboru Higuchi; Shigemi Kameda; Hideaki Tahara; Jun-Ichi Miyazaki; Fumitake Gejyo
Effects of viral interleukin 10 introduced by in vivo electroporation on arthrogen-induced arthritis in mice.
The Journal of rheumatology 2006;33(3):455-62.
2006: Junichiro James Kazama; Suguru Yamamoto; Naoki Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Abeta-2M-amyloidosis and related bone diseases.
Journal of bone and mineral metabolism 2006;24(2):182-4.
2005: Junichiro James Kazama; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Maxacalcitol is a possible less phosphatemic vitamin D analog.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(4):352-4.
2005: Junichiro James Kazama; Kentaro Omori; N Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Y Iwasaki; Masafumi Fukagawa
Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients with secondary hyperparathyroidism.
Clinical nephrology 2005;64(1):64-8.
2005: Yuko Oyama; Junichiro James Kazama; Kentaro Omori; Noboru Higuchi; Shigemi Kameda; Suguru Yamamoto; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Clinical and experimental nephrology 2005;9(2):142-7.
2005: Hiroki Maruyama; Noboru Higuchi; Shigemi Kameda; Gen Nakamura; Masaaki Shimotori; Noriaki Iino; Masato Higuchi; Tomohiro Neichi; Sadaaki Yokoyama; Toru Kono; Jun-ichi Miyazaki; Fumitake Gejyo
Sustained transgene expression in rat kidney with naked plasmid DNA and PCR-amplified DNA fragments.
Journal of biochemistry 2005;137(3):373-80.
2005: Junichiro James Kazama; Fuminori Sato; Kentaro Omori; Hitomi Hama; Suguru Yamamoto; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Takeyoshi Yamashita; Seiji Fukumoto; Masafumi Fukagawa
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.
Kidney international 2005;67(3):1120-5.
2005: Junichiro James Kazama; Suguru Yamamoto; Shigemi Kameda; Hiroki Maruyama; Ichiei Narita; Takashi Shigematsu; Fumitake Gejyo
Direct comparison between two 1-84PTH assays in dialysis patients.
Nephron. Clinical practice 2005;99(1):c8-12.
2005: Hiroki Maruyama; Jun-Ichi Miyazaki; Fumitake Gejyo
Epidermis-targeted gene transfer using in vivo electroporation.
Methods in molecular biology (Clifton, N.J.) 2005;289():431-6.
2004: Noboru Higuchi; Hiroki Maruyama
[Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
Clinical calcium 2004;14(5):744-9.
2004: Hiroki Maruyama; Noboru Higuchi; Shigemi Kameda; Gen Nakamura; Seitaro Iguchi; Jun-Ichi Miyazaki; Fumitake Gejyo
Rat kidney-targeted naked plasmid DNA transfer by retrograde injection into the renal vein.
Molecular biotechnology 2004;27(1):23-31.
2004: Fumitake Gejyo; Yoshindo Kawaguchi; Shigeko Hara; Ryoichi Nakazawa; Nakanobu Azuma; Hiroshi Ogawa; Yutaka Koda; Masashi Suzuki; Hiroshi Kaneda; Hidefumi Kishimoto; Mizue Oda; Kyoko Ei; Ryoichi Miyazaki; Hiroki Maruyama; Masaaki Arakawa; Mitsuru Hara
Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
Artificial organs 2004;28(4):371-80.
2004: Shigemi Kameda; Hiroki Maruyama; Noboru Higuchi; Noriaki Iino; Gen Nakamura; Jun-Ichi Miyazaki; Fumitake Gejyo
Kidney-targeted naked DNA transfer by retrograde injection into the renal vein in mice.
Biochemical and biophysical research communications 2004;314(2):390-5.
2004: Hiroki Maruyama; Masato Higuchi; Noboru Higuchi; Shigemi Kameda; M Saito; M Sugawa; J Matsuzaki; Tomohiro Neichi; S Yokoyama; Y Miyazaki; Jun-Ichi Miyazaki; Fumitake Gejyo
Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
The journal of gene medicine 2004;6(2):228-37.
2004: Hiroki Maruyama; Noboru Higuchi; Shigemi Kameda; Jun-Ichi Miyazaki; Fumitake Gejyo
Rat liver-targeted naked plasmid DNA transfer by tail vein injection.
Molecular biotechnology 2004;26(2):165-72.
2003: Junichiro James Kazama; K Suzuki; A Yokoseki; Akihisa Oyanagi; S Goto; H Shimada; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patient with non-uremic secondary hyperparathyroidism.
Clinical nephrology 2003;60(5):369-71.
2003: Shigemi Kameda; Hiroki Maruyama; Noboru Higuchi; Gen Nakamura; Noriaki Iino; Yuji Nishikawa; Jun-Ichi Miyazaki; Fumitake Gejyo
Hydrodynamics-based transfer of PCR-amplified DNA fragments into rat liver.
Biochemical and biophysical research communications 2003;309(4):929-36.
2003: Ken Ataka; Hiroki Maruyama; Tomohiro Neichi; Jun-ichi Miyazaki; Fumitake Gejyo
Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
American journal of nephrology 2003;23(5):315-23.
2003: Hiroshi Kikuchi; Hiroki Maruyama; Saori Omori; Junichiro James Kazama; Fumitake Gejyo
The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2003;7(4):456-60.
2003: Noboru Higuchi; Hiroki Maruyama; Takeshi Kuroda; Shigemi Kameda; Noriaki Iino; Hiroshi Kawachi; Yuji Nishikawa; H Hanawa; H Tahara; Jun-Ichi Miyazaki; Fumitake Gejyo
Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats.
Gene therapy 2003;10(16):1297-310.
2003: Junichiro James Kazama; Tsukasa Omori; Isei Ei; Kyoko Ei; Mizue Oda; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
Clinical and experimental nephrology 2003;7(2):144-9.
2003: Yuko Oyama; Junichiro James Kazama; Hiroki Maruyama; Ichiei Narita; Chizuko Kanbayashi; Yu Koyama; Tsukasa Omori; Katsuyoshi Hatakeyama; Fumitake Gejyo
Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii76-8.
2003: Junichiro James Kazama; N Takahashi; Yumi Ito; Y Watanabe; Noriaki Iino; Seitaro Iguchi; Akihisa Oyanagi; H Obayashi; S Ito; Hiroki Maruyama; Ichiei Narita; S Yamamoto; Y Sato; A Tsuchiya; T Ichida; Fumitake Gejyo
Successful perioperative blood purification therapy in patients with maintenance hemodialysis therapy who underwent living donor liver transplantation.
Clinical nephrology 2003;59(3):229-33.
2002: Hiroki Maruyama; Noboru Higuchi; Yuji Nishikawa; Shigemi Kameda; Noriaki Iino; Junichiro James Kazama; N Takahashi; M Sugawa; H Hanawa; N Tada; Jun-Ichi Miyazaki; Fumitake Gejyo
High-level expression of naked DNA delivered to rat liver via tail vein injection.
The journal of gene medicine 2002;4(3):333-41.
2002: Junichiro James Kazama; Keiko Kutsuwada; Ken Ataka; Hiroki Maruyama; Fumitake Gejyo
Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases.
Nephron 2002;91(1):13-20.
2002: Hiroki Maruyama; Noboru Higuchi; Yuji Nishikawa; Hiroyuki Hirahara; Noriaki Iino; Shigemi Kameda; Hiroshi Kawachi; Eishin Yaoita; Fumitake Gejyo; Jun-Ichi Miyazaki
Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats.
Human gene therapy 2002;13(3):455-68.
2002: Kiyoko Sato; Junichiro James Kazama; Yoko Wada; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Kentaro Sugiyama; Hiroshi Satoh
Hypersensitivity to paraoxybenzoic Acid esters (parabens) in a dialysis patient.
Nephron 2002;92(3):728-9.
2001: Hiroki Maruyama; Ken Ataka; Noboru Higuchi; F Sakamoto; Fumitake Gejyo; Jun-Ichi Miyazaki
Skin-targeted gene transfer using in vivo electroporation.
Gene therapy 2001;8(23):1808-12.
2001: Hiroki Maruyama; Ken Ataka; Fumitake Gejyo; Noboru Higuchi; Y Ito; H Hirahara; Ikuo Imazeki; M Hirata; F Ichikawa; Tomohiro Neichi; H Kikuchi; M Sugawa; Jun-Ichi Miyazaki
Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats.
Gene therapy 2001;8(6):461-8.
2001: Junichiro James Kazama; Hiroki Maruyama; Fumitake Gejyo
Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 4():31-5.
2000: Hiroki Maruyama; M Sugawa; Y Moriguchi; Ikuo Imazeki; Y Ishikawa; Ken Ataka; S Hasegawa; Y Ito; Noboru Higuchi; Junichiro James Kazama; Fumitake Gejyo; Jun-Ichi Miyazaki
Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation.
Human gene therapy 2000;11(3):429-37.
1999: Hiroki Maruyama; T Tanizawa; S Uchiyama; T Higuchi; Kyoko Ei; Mizue Oda; Isei Ei; M Oya; H Kishimoto; T Saito; S Miyamura; Y Takano; S Hasegawa; K Kawada; K Ueki; Y Iwafuchi; Masaaki Arakawa
Magnetic resonance imaging of pseudotumors of the craniovertebral junction in long-term hemodialysis patients.
American journal of nephrology 1999;19(5):541-5.
1998: Hiroki Maruyama; H Shimada; H Obayashi; T Nakamaru; Y Miyakawa; S Goto; T Ogihara; K Takakuwa; K Tanaka; H Kishimoto; Y Yuasa; S Sakai; H Okajima; S Suzuki; Masaaki Arakawa
Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients.
Nephron 1998;79(4):413-9.
1998: Hiroki Maruyama; S Omori; M Nagai; H Obayashi; T Tanizawa; Isei Ei; M Oda; Kyoko Ei; H Kishimoto; Masaaki Arakawa
Is there a female predominance in popliteal cysts in long-term haemodialysis patients?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(7):1900-1.